Sutro sets up SAB
This article was originally published in Scrip
Executive Summary
Sutro Biopharma, a San Francisco-based firm developing novel protein therapeutics, has appointed a new scientific advisory board comprising two members: James Wells, professor in pharmaceutical sciences and director of the Small Molecule Discovery Center at the University of California, San Francisco; and Professor James Swartz, a director and founder of Sutro Biopharma and a professor in the school of engineering at Stanford University. Professor Wells will serve as chair of the SAB.